53 days until earnings call
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$29.21
Change+$0.04 (+0.14%)
Volume$3.53K
Net Assets83.26M
GINX vs GSK Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Sep 06, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Hold and GSK is a Buy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 64 | |
SMR RATING 1..100 | 39 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 26 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 40% | 1 day ago 44% |
| Stochastic ODDS (%) | 1 day ago 60% | 1 day ago 46% |
| Momentum ODDS (%) | 1 day ago 73% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 63% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 60% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 53% |
| Advances ODDS (%) | 1 day ago 88% | 1 day ago 59% |
| Declines ODDS (%) | 3 days ago 59% | N/A |
| BollingerBands ODDS (%) | 1 day ago 58% | 1 day ago 50% |
| Aroon ODDS (%) | 1 day ago 87% | 1 day ago 45% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GOAU | 35.41 | 0.85 | +2.45% |
| US Global GO GOLD and Prec Mtl Mnrs ETF | |||
| FDRV | 16.09 | 0.18 | +1.11% |
| Fidelity Elctrc Vhcls & Ftr Trnsptn ETF | |||
| FNDE | 34.65 | 0.37 | +1.08% |
| Schwab Fundamental Emerging MarketsEqETF | |||
| JIVE | 73.54 | 0.26 | +0.36% |
| JPMorgan International Value ETF | |||
| XUDV | 26.54 | -0.08 | -0.30% |
| Franklin U.S. Dividend Mltplr Idx ETF | |||
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | +0.15% | ||
| GSK - GINX | 24% Poorly correlated | +2.25% | ||
| RELX - GINX | 21% Poorly correlated | +0.53% | ||
| KMB - GINX | 21% Poorly correlated | +1.55% | ||
| NVS - GINX | 20% Poorly correlated | +1.02% | ||
| KO - GINX | 20% Poorly correlated | -0.42% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y